Aesthetic Medicine Market by Products, Type, Gender, End-User

List of Tables

[183 Pages Report] The Aesthetic Medicine Market size was estimated at USD 81.81 billion in 2023 and expected to reach USD 91.59 billion in 2024, at a CAGR 12.33% to reach USD 184.65 billion by 2030.

Global Aesthetic Medicine Market

KEY MARKET STATISTICS
Base Year [2023]	USD 81.81 billion
Estimated Year [2024]	USD 91.59 billion
Forecast Year [2030]	USD 184.65 billion
CAGR (%)	12.33%

Aesthetic medicine, also known as cosmetic medicine, is a rapidly growing interdisciplinary field encompassing various medical practices to enhance the patient's appearance, self-esteem, and overall well-being through minimally invasive or non-invasive procedures. This specialized medical practice combines artistry with the latest scientific advancements to address an array of concerns related to aging, skin health, body contouring, and facial aesthetics. Technological advancements in cosmetic surgery equipment and techniques and increasing demand for non-invasive cosmetic procedures have accelerated the need for aesthetic medicines. However, limited reimbursement coverage and strict regulatory guidelines can act as barriers to increasing the use of these medicines. Advanced research in the field has led to the development of innovative aesthetic medicine products with improved safety profiles and minimal downtime post-procedure. Market players are working on integrating digital technologies such as telemedicine platforms or virtual consultations to help reach a wider audience while improving patient convenience.

Regional Insights

The Americas portrays a well-established aesthetic medicine market driven by the increased presence of well-known manufacturers, creating a competitive environment that fuels innovation and product development. Increased awareness about various non-surgical treatments, such as injectables and body contouring products in the U.S. and Canada, has accelerated the demand for aesthetic medicine in the region. In Asia-Pacific (APAC), the demand for aesthetic medicine is rapidly growing due to cultural factors such as beauty standards and increasing disposable incomes among middle-class populations. In particular, South Korean, Chinese, and Japanese consumers prioritize skincare products focusing on anti-aging benefits, creating an improved market for aesthetic medicine. Europe boasts a strong tradition of excellence in dermatology research, leading to innovations within aesthetic medicine over time. International medical tourism to countries such as Poland, Hungary, and the Czech Republic has expanded, where patients can access high-quality treatments at a lower cost. The European Medicines Agency (EMA) plays a crucial role in overseeing market authorization for aesthetic medicine products within the European Union.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aesthetic Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aesthetic Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd., Bioxis Pharmaceuticals, Black & Black Surgical, Inc., BTL Industries, Candela Corporation, Cutera, Inc., Cynosure Inc., Cytrellis, Inc., Dimeda Instrumente GmBH, Fotona d.o.o., Galderma SA, Inmode Ltd., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Lumenis Be Ltd. by Boston Scientific Corp., Lutronic Inc., Lynton Lasers Ltd., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Millennium Surgical Corp., miraDry, Inc., Quanta System S.p.A. by El.En. S.p.A., Sciton, Inc., Sientra, Inc., Sinclair Pharma Ltd., Solta Medical, Strata Skin Sciences, Venus Concept, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Products
- Body Contouring Devices
  - Cellulite Reduction Devices
  - Liposuction Devices
  - Non-Surgical Fat Reduction Devices
- Cosmetic Implants
  - Breast implants
  - Facial implants
  - Gluteal implants
- Facial Aesthetic Products
  - Botulinum toxin
  - Chemical peels
  - Derma Fillers
  - Microdermabrasion products
- Hair Removal Devices
- Nail Treatment Laser Devices
- Physician-Dispensed Eyelash Products
- Skin Aesthetic Devices
  - Laser Skin Resurfacing Sevices
  - Light Therapy Devices
  - Microneedling Devices
  - Non-surgical Skin Tightening Devices
- Tattoo Removal Devices
- Thread Lift Products
Type
- Invasive Procedures
- Non-Invasive Procedures
Gender
- Female
- Male
End-User
- Ambulatory Surgical Center
- Beauty Center & Medical Spa
- Dermatology Clinic
- Home Setting
- Hospital
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aesthetic Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aesthetic Medicine Market?

3. What are the technology trends and regulatory frameworks in the Aesthetic Medicine Market?

4. What is the market share of the leading vendors in the Aesthetic Medicine Market?

5. Which modes and strategic moves are suitable for entering the Aesthetic Medicine Market?

Product Code: MRR-B9334AD6C25A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Aesthetic Medicine Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing preference for minimally invasive reconstruction surgeries
  - 5.1.1.2. Proliferation in the number of congenital face disorders and breast deformities
  - 5.1.1.3. Growing consumer awareness about aesthetic appearance globally
- 5.1.2. Restraints
  - 5.1.2.1. High cost of the aesthetic treatments
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in aesthetic surgical procedures
  - 5.1.3.2. Introduction of advanced materials such as silicone implants in aesthetic surgery
- 5.1.4. Challenges
  - 5.1.4.1. Unfavorable reimbursement policies and stringent regulatory scenarios
5.2. Market Segmentation Analysis
- 5.2.1. Products: Rising demand for cosmetic implants to improve aesthetic appearances
- 5.2.2. End-User: Increasing number of aesthetic surgeries conducted across dermatology clinics and cosmetic centers
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Aesthetic Medicine Market, by Products

6.1. Introduction
6.2. Body Contouring Devices
- 6.3.1. Cellulite Reduction Devices
- 6.3.2. Liposuction Devices
- 6.3.3. Non-Surgical Fat Reduction Devices
6.3. Cosmetic Implants
- 6.4.1. Breast implants
- 6.4.2. Facial implants
- 6.4.3. Gluteal implants
6.4. Facial Aesthetic Products
- 6.5.1. Botulinum toxin
- 6.5.2. Chemical peels
- 6.5.3. Derma Fillers
- 6.5.4. Microdermabrasion products
6.5. Hair Removal Devices
6.6. Nail Treatment Laser Devices
6.7. Physician-Dispensed Eyelash Products
6.8. Skin Aesthetic Devices
- 6.9.1. Laser Skin Resurfacing Sevices
- 6.9.2. Light Therapy Devices
- 6.9.3. Microneedling Devices
- 6.9.4. Non-surgical Skin Tightening Devices
6.9. Tattoo Removal Devices
6.10. Thread Lift Products

7. Aesthetic Medicine Market, by Type

7.1. Introduction
7.2. Invasive Procedures
7.3. Non-Invasive Procedures

8. Aesthetic Medicine Market, by Gender

8.1. Introduction
8.2. Female
8.3. Male

9. Aesthetic Medicine Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Beauty Center & Medical Spa
9.4. Dermatology Clinic
9.5. Home Setting
9.6. Hospital

10. Americas Aesthetic Medicine Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Aesthetic Medicine Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Medicine Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
  - 13.3.1.1. ARCHIMED Buys WiQo, a Pioneer in the Field of Aesthetic Medicine
  - 13.3.1.2. Functionalab Completes Merger with FYi Medical Aesthetics, Creating the Largest Network of Premium Aesthetic Medicine Clinics in Canada
- 13.3.2. New Product Launch & Enhancement
  - 13.3.2.1. MedShift Launches SaaS Platform for Medical Aesthetic Businesses

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. AbbVie Inc.
- 14.1.2. Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd.
- 14.1.3. Bioxis Pharmaceuticals
- 14.1.4. Black & Black Surgical, Inc.
- 14.1.5. BTL Industries
- 14.1.6. Candela Corporation
- 14.1.7. Cutera, Inc.
- 14.1.8. Cynosure Inc.
- 14.1.9. Cytrellis, Inc.
- 14.1.10. Dimeda Instrumente GmBH
- 14.1.11. Fotona d.o.o.
- 14.1.12. Galderma SA
- 14.1.13. Inmode Ltd.
- 14.1.14. Johnson & Johnson Services Inc.
- 14.1.15. KARL STORZ SE & Co. KG
- 14.1.16. Lumenis Be Ltd. by Boston Scientific Corp.
- 14.1.17. Lutronic Inc.
- 14.1.18. Lynton Lasers Ltd.
- 14.1.19. Medytox Inc.
- 14.1.20. Merz Pharma GmbH & Co. KGaA
- 14.1.21. Millennium Surgical Corp.
- 14.1.22. miraDry, Inc.
- 14.1.23. Quanta System S.p.A. by El.En. S.p.A.
- 14.1.24. Sciton, Inc.
- 14.1.25. Sientra, Inc.
- 14.1.26. Sinclair Pharma Ltd.
- 14.1.27. Solta Medical
- 14.1.28. Strata Skin Sciences
- 14.1.29. Venus Concept
- 14.1.30. Zimmer Biomet Holdings, Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing